Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria

• Hauptverfasser: Zainab M. Elsayed (VerfasserIn), Wagdy M. Eldehna (VerfasserIn), Marwa M. Abdel-Aziz (VerfasserIn), Mahmoud A. El Hassab (VerfasserIn), Eslam B. Elkaeed (VerfasserIn), Tarfah Al-Warhi (VerfasserIn), Hatem A. Abdel-Aziz (VerfasserIn), Sahar M. Abou-Seri (VerfasserIn), Eman R. Mohammed (VerfasserIn)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Joining the global fight against Tuberculosis, the world's most deadly infectious disease, herein we present the design and synthesis of novel isatin-nicotinohydrazide hybrids (5a-m and 9a-c) as promising anti-tubercular and antibacterial agents. The anti-tubercular activity of the target hybri...